These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8819585)

  • 121. [Not Available].
    Oberhofer E
    MMW Fortschr Med; 2022 Jun; 164(Suppl 2):16-17. PubMed ID: 35731481
    [No Abstract]   [Full Text] [Related]  

  • 122. [Not Available].
    Bogner JR
    MMW Fortschr Med; 2022 Jun; 164(Suppl 2):5. PubMed ID: 35731473
    [No Abstract]   [Full Text] [Related]  

  • 123. Specificity of Retroviral Proteinases Based on Substrates Containing Tyrosine and Proline at the Site of Cleavage.
    Tözsér J
    Pathol Oncol Res; 1997; 3(2):142-146. PubMed ID: 11173643
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Protease inhibitors as antiviral agents.
    Patick AK; Potts KE
    Clin Microbiol Rev; 1998 Oct; 11(4):614-27. PubMed ID: 9767059
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Current knowledge and future prospects for the use of HIV protease inhibitors.
    Moyle G; Gazzard B
    Drugs; 1996 May; 51(5):701-12. PubMed ID: 8861542
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro.
    Bender AR; von Briesen H; Kreuter J; Duncan IB; Rübsamen-Waigmann H
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1467-71. PubMed ID: 8726020
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay.
    Herz AV; Bonhoeffer S; Anderson RM; May RM; Nowak MA
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7247-51. PubMed ID: 8692977
    [TBL] [Abstract][Full Text] [Related]  

  • 128. [HIV: less resistance due to combined treatment].
    Dtsch Med Wochenschr; 1996 Dec; 121(49):A47-8. PubMed ID: 8998914
    [No Abstract]   [Full Text] [Related]  

  • 129. HIV-protease inhibitors.
    Flexner C
    N Engl J Med; 1998 Apr; 338(18):1281-92. PubMed ID: 9562584
    [No Abstract]   [Full Text] [Related]  

  • 130. HIV protease inhibitors.
    Winslow DL; Otto MJ
    AIDS; 1995; 9 Suppl A():S183-92. PubMed ID: 8819585
    [No Abstract]   [Full Text] [Related]  

  • 131. Update of the drug resistance mutations in HIV-1: 2004.
    Johnson VA; Brun-Vézinet F; Clotet B; Conway B; D'Aquila RT; Demeter LM; Kuritzkes DR; Pillay D; Schapiro JM; Telenti A; Richman DD
    Top HIV Med; 2004; 12(4):119-24. PubMed ID: 15516709
    [No Abstract]   [Full Text] [Related]  

  • 132. [Primary resistance to antiretroviral agents].
    Soriano V; María Miró J; Guerrero A
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):22-5. PubMed ID: 11428054
    [No Abstract]   [Full Text] [Related]  

  • 133.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 134.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 135.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 136.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 137.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 138.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 139.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 140.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.